If any of the following apply to you/the person being immunised, please advise the healthcare professional:
- Received a COVID-19 immunisation
- Currently unwell with a high fever
- Allergic to any food or medicine Influenza vaccination
- Taking blood thinning medication or have a bleeding disorder
- Had a severe response to an influenza immunisation in the past
Possible responses to influenza immunisation
Influenza immunisation is usually well tolerated.
Possible responses include pain, redness and/or swelling at the injection site for a day or two; a mild fever, muscle aches or headache within the first two days. Rarely, an allergic response can occur.
You/the immunised person should remain under observation in case of an allergic response. You will be advised how long to wait; this could be up to 20 minutes.
Influenza immunisation does not protect against other respiratory viruses such as the common cold. Talk to your healthcare professional about the benefits and possible risks. For more information about the influenza vaccine, please refer to the consumer medicine information sheet located at www.medsafe.govt.nz
National Immunisation Register
The Ministry of Health keeps a record of influenza immunisations on the National Immunisation Register so that authorised healthcare professionals can find out what immunisations have been given. If you do not want your immunisation recorded on the National Immunisation Register, please advise your healthcare professional.
By attending your appointment, we will assume that you,
- have read or have had explained information about influenza immunisation, including how long to wait after the immunisation.
- have had a chance to ask questions and they were answered to my satisfaction.
- believe you understand the benefits and possible risks of influenza immunisation.
- understand that influenza immunisation is a choice.
- consent to the influenza immunisation being given.
- agree for this immunisation information to be shared with my/the immunised person’s regular healthcare provider.
FUNDED FLU VAX 2021
⦁ Is ONLY approved for use in adults aged 65 years and older
⦁ Funded for adults who are eligible to receive publicly funded healthcare services in NZ.
AFLURIA QUAD JUNIOR
⦁ For children aged under 3 years, i.e 6-35 months.
⦁ Funded for children who meet the influenza eligibility criteria
⦁ Available for those who do not meet the funded eligibility criteria at a cost.
⦁ Funded for children and adults who meet the influenza vaccination eligibility criteria.
⦁ Available for those who do not meet the funded eligibility criteria at a cost
The 2021 vaccines will be quadrivalent influenza vaccines that contain the following four influenza strains, the first two strains are new to the 2021 vaccine:
⦁ A/Victoria/2570/2019 (H1N1)pdm09-like virus
⦁ A/Hong Kong/2671/2019 (H3N2)-like virus
⦁ B/Washington/02/2019-like virus
⦁ B/Phuket/3073/2013-like virus